TY - JOUR
T1 - Screening initiation with FIT or colonoscopy
T2 - Post-hoc analysis of a pragmatic, randomized trial
AU - Murphy, Caitlin Claffey
AU - Ahn, Chul
AU - Pruitt, Sandi
AU - Hughes, Amy E.
AU - Halm, Ethan A
AU - Gupta, Samir
AU - Santini, Noel O.
AU - McCallister, Katharine
AU - Sanders, Joanne M.
AU - Singal, Amit
AU - Skinner, Celette S
N1 - Funding Information:
This work was supported by the National Cancer Institute ( U54 CA163308 , P30 CA142543 ) and National Center for Advancing Translational Sciences ( KL2 TR001103 to Dr. Murphy) at the National Institutes of Health . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Publisher Copyright:
© 2018
PY - 2019/1
Y1 - 2019/1
N2 - Screening with FIT or colonoscopy can reduce CRC mortality. In our pragmatic, randomized trial of screening outreach over three years, patients annually received mailed FITs or colonoscopy invitations. We examined screening initiation after each mailing and crossover from the invited to other modality. Eligible patients (50–64 years, ≥1 primary-care visit before randomization, and no history of CRC) received mailed FIT kits (n = 2400) or colonoscopy invitations (n = 2400) from March 2013 through July 2016. Among those invited for colonoscopy, we used multinomial logistic regression to identify factors associated with screening initiation with colonoscopy vs. FIT vs. no screening after the first mailing. Most patients were female (61.8%) and Hispanic (48.9%) or non-Hispanic black (24.0%). Among those invited for FIT, 56.6% (n = 1359) initiated with FIT, whereas 3.3% (n = 78) crossed over to colonoscopy; 151 (15.7%) and 61 (7.7%) initiated with FIT after second and third mailings. Among those invited for colonoscopy, 25.5% (n = 613) initiated with colonoscopy whereas 18.8% (n = 452) crossed over to FIT; 112 (8.4%) and 48 (4.2%) initiated with colonoscopy after second and third mailings. Three or more primary-care visits prior to randomization were associated with initiating with colonoscopy (OR 1.49, 95% CI 1.17–1.91) and crossing over to FIT (OR 1.63, 95% CI 1.19–2.23). Although nearly half of patients initiated screening after the first mailing, few non-responders in either outreach group initiated after a second or third mailing. More patients invited to colonoscopy crossed over to FIT than those assigned to FIT crossed over to colonoscopy.
AB - Screening with FIT or colonoscopy can reduce CRC mortality. In our pragmatic, randomized trial of screening outreach over three years, patients annually received mailed FITs or colonoscopy invitations. We examined screening initiation after each mailing and crossover from the invited to other modality. Eligible patients (50–64 years, ≥1 primary-care visit before randomization, and no history of CRC) received mailed FIT kits (n = 2400) or colonoscopy invitations (n = 2400) from March 2013 through July 2016. Among those invited for colonoscopy, we used multinomial logistic regression to identify factors associated with screening initiation with colonoscopy vs. FIT vs. no screening after the first mailing. Most patients were female (61.8%) and Hispanic (48.9%) or non-Hispanic black (24.0%). Among those invited for FIT, 56.6% (n = 1359) initiated with FIT, whereas 3.3% (n = 78) crossed over to colonoscopy; 151 (15.7%) and 61 (7.7%) initiated with FIT after second and third mailings. Among those invited for colonoscopy, 25.5% (n = 613) initiated with colonoscopy whereas 18.8% (n = 452) crossed over to FIT; 112 (8.4%) and 48 (4.2%) initiated with colonoscopy after second and third mailings. Three or more primary-care visits prior to randomization were associated with initiating with colonoscopy (OR 1.49, 95% CI 1.17–1.91) and crossing over to FIT (OR 1.63, 95% CI 1.19–2.23). Although nearly half of patients initiated screening after the first mailing, few non-responders in either outreach group initiated after a second or third mailing. More patients invited to colonoscopy crossed over to FIT than those assigned to FIT crossed over to colonoscopy.
KW - Colorectal neoplasms
KW - Health promotion
KW - Mass screening
KW - Pragmatic clinical trial
KW - Safety-net providers
UR - http://www.scopus.com/inward/record.url?scp=85057785145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057785145&partnerID=8YFLogxK
U2 - 10.1016/j.ypmed.2018.11.020
DO - 10.1016/j.ypmed.2018.11.020
M3 - Article
C2 - 30508552
AN - SCOPUS:85057785145
SN - 0091-7435
VL - 118
SP - 332
EP - 335
JO - Preventive Medicine
JF - Preventive Medicine
ER -